pI: 6.5401 |
Length (AA): 852 |
MW (Da): 93853 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
122 | 757 | 1jey (A) | 38 | 534 | 22.00 | 0 | 1 | 0.66 | 0.94 |
787 | 843 | 1jjr (A) | 44 | 94 | 22.00 | 0.000042 | 0.59 | 0.39 | -1.63 |
17 | 143 | 4b4h (A) | 398 | 529 | 28.00 | 0.96 | 0.52 | 0.307061 | 0.66 |
116 | 846 | 1jeq (A) | 35 | 609 | 21.00 | 0 | 1 | 0.680581 | 1.49 |
117 | 302 | 5ln1 (A) | 4 | 149 | 16.00 | 0.019 | 0.5 | 0.14491 | 0.05 |
140 | 321 | 4bz7 (A) | 63 | 246 | 28.00 | 0.92 | 0.18 | 0.126615 | 1.07 |
793 | 851 | 2rno (A) | 0 | 53 | 23.00 | 0.064 | 0.14 | 0.312849 | -0.38 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | epimastigote. | Smircich P |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_129086)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G16970 | ATP-dependent DNA helicase 2 subunit KU70 |
Brugia malayi | Bm1_41430 | ATP-dependent DNA helicase II, 70 kDa subunit |
Candida albicans | CaO19.3491 | one of two closely related genes similar to S. cerevisiae YKU70 (YMR284W) Ku70-like DNA binding protein subunit involved in nonh |
Candida albicans | CaO19.1135 | one of two closely related genes similar to S. cerevisiae YKU70 (YMR284W) Ku70-like DNA binding protein subunit involved in nonh |
Candida albicans | CaO19.8728 | one of two closely related genes similar to S. cerevisiae YKU70 (YMR284W) Ku70-like DNA binding protein subunit involved in nonh |
Caenorhabditis elegans | CELE_Y47D3A.4 | Protein CKU-70 |
Dictyostelium discoideum | DDB_G0286069 | ATP-dependent DNA helicase |
Drosophila melanogaster | Dmel_CG5247 | Inverted repeat-binding protein |
Echinococcus granulosus | EgrG_000843250 | x ray repair cross complementing protein 6 |
Echinococcus multilocularis | EmuJ_000843250 | x ray repair cross complementing protein 6 |
Homo sapiens | ENSG00000196419 | X-ray repair complementing defective repair in Chinese hamster cells 6 |
Leishmania braziliensis | LbrM.29.1130 | KU70 protein, putative |
Leishmania donovani | LdBPK_291140.1 | KU70 protein, putative |
Leishmania infantum | LinJ.29.1140 | KU70 protein, putative |
Leishmania major | LmjF.29.1050 | KU70 protein, putative |
Leishmania mexicana | LmxM.08_29.1050 | KU70 protein, putative |
Loa Loa (eye worm) | LOAG_01147 | hypothetical protein |
Mus musculus | ENSMUSG00000022471 | X-ray repair complementing defective repair in Chinese hamster cells 6 |
Neospora caninum | NCLIV_064150 | ATP-dependent DNA helicase II, 70 kDa subunit, putative |
Oryza sativa | 4342584 | Os07g0184900 |
Saccharomyces cerevisiae | YMR284W | Yku70p |
Schistosoma japonicum | Sjp_0065680 | ko:K01303 acylaminoacyl-peptidase [EC3.4.19.1], putative |
Schistosoma japonicum | Sjp_0047080 | hypothetical protein |
Schistosoma japonicum | Sjp_0065690 | ATP-dependent DNA helicase 2 subunit 1, putative |
Schistosoma mansoni | Smp_146670 | acylaminoacyl-peptidase (S09 family) |
Schmidtea mediterranea | mk4.001927.02 | Acylaminoacyl-peptidase |
Trypanosoma brucei gambiense | Tbg972.3.5630 | KU70 protein, putative |
Trypanosoma brucei | Tb927.3.5030 | KU70 protein |
Trypanosoma congolense | TcIL3000_0_22830 | KU70 protein |
Trypanosoma cruzi | TcCLB.503643.10 | KU70 protein, putative |
Trypanosoma cruzi | TcCLB.504121.10 | KU70 protein, putative |
Toxoplasma gondii | TGME49_248160 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.5030 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.5030 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.5030 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.5030 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_248160 | Toxoplasma gondii | Essentiality uncertain | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.